NFKB1 and glioma: Our findings that Bmi-1 modulates the NF-κB/VEGF-C signaling pathway to mediate an angiogenesis phenotype in human gliomas further suggests that Bmi-1 may represent a prospective therapeutic target for anti-angiogenic strategies against the disease.